Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
AstraZeneca has teamed up with Repositive to share molecular data from patient-derived xenografts.
Florence Healthcare has picked up seed funding to help clinical trial sites switch from paper files to the cloud.
Immuno-oncology upstart Forty Seven has tapped Medidata for technology as it gears up for two early-stage clinical trials.
The Garvan Institute has founded a whole genome sequencing subsidiary, given it access to an Illumina HiSeq X Ten and tapped DNAnexus for its cloud platform.
The Scripps Research Institute has rolled out DataDirect Networks’ data management system across its cryo-electron microscopy research teams.
Biogen has made Medidata Rave its primary clinical trial technology platform, continuing the shift in power in the eClinical market.
HHS has set up a challenge to identify ways in which blockchain can support privacy, security and scalability in health IT and research data.
A team at Cincinnati Children's Hospital Medical Center has created a tool to improve analysis of adverse event data gathered by FDA.
Siemens Venture Capital has invested in Riffyn, a developer of R&D design software that is weeks away from introducing its first commercial product.
Genedata has landed a deal with Evotec, continuing a busy 18-month period in which it has signed up Bayer, Boehringer Ingelheim and Merck KGaA.